The most important consideration of graft survival is the ability to control rejection. The relatively short maximum cold ischemic time of the liver precludes HLA typing and leukocyte cross ...

CHLA leads the country in one- and three-year liver graft and patient survival for pediatric liver transplants—and is among the top hospitals in transplant volume.